<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 21 Apr 2026 15:36:31 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/idiopathic/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Chronic Idiopathic Constipation (CIC) Treatment Market, By Drug Type Linaclotide, Plecanatide]]></title><description><![CDATA[Constipation is condition wherein the stool frequency reduces up to three times per week with difficulty in stool passing. Chronic constipation is a highly common functional gastrointestinal disorder that]]></description><link>http://direct.ecency.com/chronic/@chaitanyag/chronic-idiopathic-constipation-cic-treatment-market-by-drug-type-linaclotide-plecanatide</link><guid isPermaLink="true">http://direct.ecency.com/chronic/@chaitanyag/chronic-idiopathic-constipation-cic-treatment-market-by-drug-type-linaclotide-plecanatide</guid><category><![CDATA[chronic]]></category><dc:creator><![CDATA[chaitanyag]]></dc:creator><pubDate>Tue, 26 Jun 2018 10:02:30 GMT</pubDate></item><item><title><![CDATA[Idiopathic thrombocytopenic purpura (ITP)Awareness]]></title><description><![CDATA[Hi world! My name is Waqiuddin. People called me Waqi. I'm 8 months old. Today, I would like to share with all of you about Idiopathic thrombocytopenic purpura (ITP) which attacked me at age of 3 months]]></description><link>http://direct.ecency.com/idiopathic/@waqiuddin/idiopathic-thrombocytopenic-purpura-itp-awareness</link><guid isPermaLink="true">http://direct.ecency.com/idiopathic/@waqiuddin/idiopathic-thrombocytopenic-purpura-itp-awareness</guid><category><![CDATA[idiopathic]]></category><dc:creator><![CDATA[waqiuddin]]></dc:creator><pubDate>Wed, 15 Nov 2017 02:12:24 GMT</pubDate><enclosure url="https://images.ecency.com/p/3W72119s5BjWPGGUiZ9pqnZoj8JHYxCCp9dtn2QVg8V5SfCt26LLkNLSmY1Yd4PZD2EbDbtPFfobNnrfrUfihy4DHSRnyepCs2PfGqL9Dnkz7YaYuazomY?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Linaclotide to Lead the Global Chronic Idiopathic Constipation Drugs Market at a CAGR over 7% during 2016 - 2022: Credence Research]]></title><description><![CDATA[The latest market report published by Credence Research, Inc. “Global Chronic Idiopathic Constipation (CIC) Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,”]]></description><link>http://direct.ecency.com/chronic/@david23/linaclotide-to-lead-the-global-chronic-idiopathic-constipation-drugs-market-at-a-cagr-over-7-during-2016-2022-credence-research</link><guid isPermaLink="true">http://direct.ecency.com/chronic/@david23/linaclotide-to-lead-the-global-chronic-idiopathic-constipation-drugs-market-at-a-cagr-over-7-during-2016-2022-credence-research</guid><category><![CDATA[chronic]]></category><dc:creator><![CDATA[david23]]></dc:creator><pubDate>Fri, 13 Oct 2017 05:42:48 GMT</pubDate></item></channel></rss>